The Exchange has sought clarification from RPG Life Sciences Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is awaited.
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE has asked RPG Life Sciences to clarify why its financial results for the quarter ended 31 December 2025 were not submitted in the format prescribed under Schedule III of the Companies Act, 2013 or per Indian Accounting Standards (Ind AS). The query was raised under Regulation 33 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations. The company's response is currently awaited. This is a routine procedural compliance query from the exchange regarding the format of quarterly financial submissions.
For retail investors, this is a compliance-level query and not a penalty, investigation, or trading restriction. However, if the company fails to respond satisfactorily or corrects its filing, it could attract further regulatory action or draw scrutiny on its financial reporting quality.